The invention relates to an improved process for synthesis of anti-Parkinson compound from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%.
Patent No:
US9475757
Application No:
14/888697
Filing Date:
02-11-2015
Issue Date:
25-10-2016
Applicant:
CSIR-National Chemical Laboratory (CSIR-NCL), Pune
Accessibility Controls